Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial
Go back to Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial| Bemis Company (NYSE: BMS) | Delayed: 57.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.25 | 52 Week High | $54.19 | |||
| Open | $68.29 | 52 Week Low | $42.45 | |||
| Day High | $57.25 | P/E | 28.06 | |||
| Day Low | $57.25 | EPS | $2.04 | |||
| Volume | 85,365 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 57.13 +0.23 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.90 | 52 Week High | $77.12 | |||
| Open | $57.45 | 52 Week Low | $49.03 | |||
| Day High | $57.60 | P/E | 37.10 | |||
| Day Low | $56.77 | EPS | $1.54 | |||
| Volume | 7,839,148 | |||||
| (NYSE: RCUS) | Delayed: 23.80 +0.50 (2.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.30 | 52 Week High | $ | |||
| Open | $23.50 | 52 Week Low | $ | |||
| Day High | $24.11 | P/E | N/A | |||
| Day Low | $23.27 | EPS | $ | |||
| Volume | 1,447,474 | |||||

